Literature DB >> 9768536

Estimating the cost of lost productivity in dyspepsia.

J L Severens1, R J Laheij, J B Jansen, E H Van der Lisdonk, A L Verbeek.   

Abstract

BACKGROUND: In the field of gastrointestinal disease, productivity costs are highly relevant because work loss is substantial in dyspeptic patients. Productivity costs are normally calculated by multiplying days absent valued by gross earnings. This, however, might lead to an overestimation. AIM: To use a conservative approach to calculating productivity costs, taking absence compensating mechanisms into account.
METHODS: Patients who visited their general practitioner for the first time with dyspeptic complaints and patients who were known to have persistent dyspeptic complaints were enrolled in two studies. In total, 136 patients completed a questionnaire about their employment situation, absence from work and absence compensating mechanisms.
RESULTS: Sixty-six of the respondents had a paid job, of which 25 (38%) reported absence from work during the previous 4 weeks (average 3.0 days, 1.9 days related to dyspeptic complaints). More than 50% of the employed respondents answered that absence could be compensated for by colleagues, and only in 8% of the cases was absence compensated for by overtime. Using our conservative approach, only one-quarter of the productivity costs remained, compared to the current approach of valuing each day absent as a loss of productivity.
CONCLUSIONS: We suggest using both the current and the conservative approaches, analogous to the principles of sensitivity analysis, to avoid overestimation of productivity costs.

Entities:  

Mesh:

Year:  1998        PMID: 9768536     DOI: 10.1046/j.1365-2036.1998.00376.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  15 in total

Review 1.  The relationship between productivity and health-related QOL: an exploration.

Authors:  Werner B F Brouwer; Willem-Jan Meerding; Leida M Lamers; Johan L Severens
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 2.  Productivity costs in economic evaluations: past, present, future.

Authors:  Marieke Krol; Werner Brouwer; Frans Rutten
Journal:  Pharmacoeconomics       Date:  2013-07       Impact factor: 4.981

Review 3.  Estimating productivity costs in health economic evaluations: a review of instruments and psychometric evidence.

Authors:  Kenneth Tang
Journal:  Pharmacoeconomics       Date:  2015-01       Impact factor: 4.981

4.  How to estimate productivity costs in economic evaluations.

Authors:  Marieke Krol; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

5.  Health-related productivity loss: NICE to recognize soon, good to discuss now.

Authors:  Wei Zhang; Aslam H Anis
Journal:  Pharmacoeconomics       Date:  2014-05       Impact factor: 4.981

Review 6.  Valuing patient and caregiver time: a review of the literature.

Authors:  Jennifer E Tranmer; Denise N Guerriere; Wendy J Ungar; Peter C Coyte
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

7.  The relationship between productivity and health-related quality of life: an empirical exploration in persons with low back pain.

Authors:  Leida M Lamers; Willem-Jan Meerding; Johan L Severens; Werner B F Brouwer
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

8.  Different approaches to valuing the lost productivity of patients with migraine.

Authors:  J H Lofland; J C Locklear; K D Frick
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

9.  Lost productivity in four European countries among patients with rheumatic disorders: are absenteeism and presenteeism transferable?

Authors:  Saskia Knies; Math J J M Candel; Annelies Boonen; Silvia M A A Evers; Andre J H A Ament; Johan L Severens
Journal:  Pharmacoeconomics       Date:  2012-09-01       Impact factor: 4.981

10.  Cost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study).

Authors:  Mayke B G Koek; Vigfús Sigurdsson; Huib van Weelden; Paul H A Steegmans; Carla A F M Bruijnzeel-Koomen; Erik Buskens
Journal:  BMJ       Date:  2010-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.